Literature DB >> 15550067

Influence of thyroid autoimmunity and maternal age on the risk of miscarriage.

Lino Sieiro Netto1, Claudia Medina Coeli, Eduardo Micmacher, Sheila Mamede Da Costa, Luiz Nazar, Daut Galvão, Alexandru Buescu, Mario Vaisman.   

Abstract

OBJECTIVES: Recently, studies have shown an association between antiperoxidase for the detection of thyroid autoimmunity (TAI) and abortion. Another point to be considered is the association of high risk of abortion and maternal age. The aim of the present study was to evaluate if the association between TAI and miscarriage could also be verified whether a population of unselected pregnant young women who normally present a low risk of miscarriage.
MATERIALS AND METHODS: We studied 534 pregnant women, by determining their serum thyroid antiperoxidase antibodies (TPO-Abs), thyrotropin (TSH) and free thyroxine (fT4) levels. Our end point was the pregnancy loss or live birth.
RESULTS: Age ranged from 12 to 49 years (mean +/- S.D.; 23.5 +/- 5.9). Of 534 women, 29 (5.4%) were TPO-Ab positive. TSH levels were significantly higher in TPO-Ab-positive women compared with TPO-Ab negative women (median; 1.9 versus 1.1; P = 0.001). Elevated TSH levels were found in 13.8% (4 of 29) of the TPO-Ab-positive women compared with only 2.4% (12 of 505) in the TPO-Ab-negative women. There were no significant differences in fT4 levels in relation with autoimmunity and risk of miscarriage. The overall risk of miscarriage was 2.4% (13 of 534). Risk of miscarriage was significantly higher among women older than 35 years (7.7%), TPO-Ab positive (10.3%) and presenting high levels of TSH (12.5%). These factors remained independently associated with the risk of miscarriage in full multivariate analysis.
CONCLUSIONS: We conclude that TAI is independently associated with is a higher risk of miscarriage in a population of unselected pregnant presenting a low risk of miscarriage.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15550067     DOI: 10.1111/j.1600-0897.2004.00227.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  6 in total

1.  Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum.

Authors:  Alex Stagnaro-Green; Marcos Abalovich; Erik Alexander; Fereidoun Azizi; Jorge Mestman; Roberto Negro; Angelita Nixon; Elizabeth N Pearce; Offie P Soldin; Scott Sullivan; Wilmar Wiersinga
Journal:  Thyroid       Date:  2011-07-25       Impact factor: 6.568

2.  Euthyroid women with autoimmune disease undergoing assisted reproduction technologies: the role of autoimmunity and thyroid function.

Authors:  R Negro; G Formoso; L Coppola; G Presicce; T Mangieri; A Pezzarossa; D Dazzi
Journal:  J Endocrinol Invest       Date:  2007-01       Impact factor: 4.256

3.  Subclinical Hypothyroidism and Thyroid Autoimmunity Are Not Associated With Fecundity, Pregnancy Loss, or Live Birth.

Authors:  Torie C Plowden; Enrique F Schisterman; Lindsey A Sjaarda; Shvetha M Zarek; Neil J Perkins; Robert Silver; Noya Galai; Alan H DeCherney; Sunni L Mumford
Journal:  J Clin Endocrinol Metab       Date:  2016-03-29       Impact factor: 5.958

4.  Relationship between antithyroid antibody and pregnancy outcome following in vitro fertilization and embryo transfer.

Authors:  Yi-ping Zhong; Ying Ying; Hai-tao Wu; Can-quan Zhou; Yan-wen Xu; Qiong Wang; Jie Li; Xiao-ting Shen; Jin Li
Journal:  Int J Med Sci       Date:  2012-01-05       Impact factor: 3.738

Review 5.  Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence.

Authors:  Shakila Thangaratinam; Alex Tan; Ellen Knox; Mark D Kilby; Jayne Franklyn; Arri Coomarasamy
Journal:  BMJ       Date:  2011-05-09

6.  Lifetime Prevalence of Abortion and Risk Factors in Women: Evidence from a Cohort Study.

Authors:  Mehdi Moradinazar; Farid Najafi; Zeinab Moradi Nazar; Behrooz Hamzeh; Yahya Pasdar; Ebrahim Shakiba
Journal:  J Pregnancy       Date:  2020-04-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.